CVE detail

CVE-2021-47858 — CVE-2021-47858

Published 2026-01-21 · Modified 2026-06-17 · Source nvd

HIGH

severity

CVSS-derived band

7.2

CVSS v3

0–10 scale

0.0024

EPSS probability

exploitation probability, 30d

15.0%

EPSS percentile

percentile vs all CVEs

NOT LISTED

CISA KEV

known exploited catalog

Description

Genexis Platinum-4410 P4410-V2-1.31A contains a stored cross-site scripting vulnerability in the 'start_addr' parameter of the Security Management interface. Attackers can inject malicious scripts through the start source address field that will persist and trigger for privileged users when they access the security management page.

Remediation

No vendor-published fix data in our corpus for this CVE. Check the references below or the vendor's PSIRT / security advisories page.

References

cvedb.io · NVD · CISA KEV · FIRST EPSS · vendor advisories (CVE Program List v5). Informational only, no warranty — verify every remediation against the vendor advisory before acting on it. This product uses data from the NVD API but is not endorsed or certified by the NVD, CISA, FIRST.org or any vendor named. CVE® is a registered trademark of The MITRE Corporation.